Amia Capital LLP Fate Therapeutics Inc Transaction History

Amia Capital LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$38.09 - $100.95 $388,860 - $1.03 Million	-10,209 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $102,512 - $136,525	3,371 Added 49.3%	10,209 $408,000
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $138,195 - $240,902	6,838 New	6,838 $235,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.